🇺🇸 Eutectic Lidocaine Prilocaine in United States

FDA authorised Eutectic Lidocaine Prilocaine on 30 December 1992

Marketing authorisations

FDA — authorised 30 December 1992

  • Application: NDA019941
  • Marketing authorisation holder: TEVA BRANDED PHARM
  • Local brand name: EMLA
  • Indication: CREAM — TOPICAL
  • Status: approved

Read official source →

FDA

  • Status: approved

Eutectic Lidocaine Prilocaine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Eutectic Lidocaine Prilocaine approved in United States?

Yes. FDA authorised it on 30 December 1992; FDA has authorised it.

Who is the marketing authorisation holder for Eutectic Lidocaine Prilocaine in United States?

TEVA BRANDED PHARM holds the US marketing authorisation.